Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,791,665 | 3,851,314 | 3,254,394 | 2,019,815 | 1,705,552 |
| Marketable Securities | 1,932,557 | 1,932,760 | 1,698,268 | 1,310,150 | 1,345,191 |
| Receivables | 8,142,708 | 7,239,903 | 6,669,377 | 6,660,232 | 7,445,721 |
| Inventories | 3,453,341 | 3,141,937 | 3,103,958 | 3,059,581 | 3,121,701 |
| Other current assets | -1 | 6 | 3 | 2 | -5 |
| TOTAL | $15,320,270 | $16,165,920 | $14,726,000 | $13,049,780 | $13,618,160 |
| Non-Current Assets | |||||
| PPE Net | 9,440,613 | 8,610,627 | 8,516,508 | 8,504,969 | 8,808,094 |
| Investments And Advances | 190,169 | 167,637 | 177,606 | 192,873 | 229,263 |
| Intangibles | 7,280,505 | 6,348,817 | 6,376,370 | 6,536,275 | 6,868,506 |
| Other Non-Current Assets | 1,930,433 | 1,562,719 | 1,510,226 | 1,444,213 | 1,422,197 |
| TOTAL | $18,841,720 | $16,689,800 | $16,580,710 | $16,678,330 | $17,328,060 |
| Total Assets | $34,161,990 | $32,855,710 | $31,306,700 | $29,728,110 | $30,946,220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 207,586 | 248,005 | 179,608 | 210,517 | 2,177,125 |
| Accounts payable and accrued liabilities | 2,207,119 | 1,124,343 | 2,095,522 | 1,007,193 | 1,411,217 |
| Other current liabilities | 13,706,310 | 15,250,610 | 12,841,690 | 12,504,490 | 11,662,670 |
| TOTAL | $17,125,100 | $17,623,770 | $15,680,670 | $14,416,780 | $15,833,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,443,429 | 3,265,601 | 3,457,454 | 3,631,867 | 2,062,095 |
| Other Non-Current Liabilities | 772,003 | 828,442 | 775,918 | 843,726 | 956,828 |
| TOTAL | $5,215,270 | $4,857,135 | $4,979,403 | $5,275,587 | $3,857,539 |
| Total Liabilities | $22,340,370 | $22,480,910 | $20,660,070 | $19,692,370 | $19,690,540 |
| Shareholders' Equity | |||||
| Common Shares | 64,570 | 61,697 | 65,208 | 69,670 | 73,504 |
| Retained earnings | 11,411,120 | 9,967,957 | 10,462,740 | 10,045,090 | 11,455,840 |
| Other shareholders' equity | 346,930 | 346,146 | 118,692 | -78,020 | -272,654 |
| TOTAL | $11,821,620 | $10,374,800 | $10,646,640 | $10,035,740 | $11,255,690 |
| Total Liabilities And Equity | $34,161,990 | $32,855,710 | $31,306,710 | $29,728,110 | $30,946,230 |